Obesity gives rise to metabolic complications by mechanisms that are poorly understood. Although chronic inflammatory signaling in adipose tissue is typically associated with metabolic deficiencies linked to excessive weight gain, we identified a subset of neuropilin-1 (NRP1)-expressing myeloid cells that accumulate in adipose tissue and protect against obesity and metabolic syndrome. Ablation of NRP1 in macrophages compromised lipid uptake in these cells, which reduced substrates for fatty acid -oxidation and shifted energy metabolism of these macrophages toward a more inflammatory glycolytic metabolism. Conditional deletion of NRP1 in LysM Cre-expressing cells leads to inadequate adipose vascularization, accelerated weight gain, and reduced insulin sensitivity even independent of weight gain. Transfer of NRP1 + hematopoietic cells improved glucose homeostasis, resulting in the reversal of a prediabetic phenotype. Our findings suggest a pivotal role for adipose tissue-resident NRP1 + -expressing macrophages in driving healthy weight gain and maintaining glucose tolerance.
INTRODUCTION
Obesity and its ensuing sequelae of metabolic syndrome, type 2 diabetes mellitus, and cardiovascular complications are in global pandemic (1) . During weight gain in response to excessive caloric intake, lipid overload in adipose tissue triggers classical macrophage polarization, cytokine release, systemic inflammation, local proliferation of adipose tissue macrophages (ATMs), and infiltration of circulating monocytes, which in concert are believed to contribute to systemic complications such as insulin resistance (2) (3) (4) (5) . This has led to a generalized association between inflammation, macrophage activation, and the pathogenesis of metabolic diseases (6) . Yet, subsets of ATMs have also been suggested to participate in lipid trafficking within adipose tissue (7) , and adipose tissue inflammation itself has been proposed to be an adaptive response permitting effective storage of excess nutrients (8) . These divergent views on adipose tissue inflammation highlight the need to tease out the characteristics of both beneficial and detrimental inflammatory processes during weight gain.
Protective adipose inflammation may be necessary for adequate tissue plasticity and angiogenesis given the role of mononuclear phagocytes in tissue remodeling and vascular growth (9, 10) . Fat pads necessitate a stable and dynamic vascular plexus to couple metabolic supply to adipocyte demands during hypertrophy and hyperplasia; thus, angiogenesis has been proposed to be a prerequisite for adipose tissue expansion (11) . Adipose vasculature also plays a key role in fatty acid (FA) transport from circulation in part through vascular endothelial growth factor B (VEGF-B)-induced FATP3 up-regulation (12) . Binding of VEGF-B to VEGF receptor 1 (VEGFR1) and its coreceptor neuropilin-1 (NRP1) increases endothelial lipid uptake. NRP1 is a multiligand single-pass transmembrane receptor originally identified as an adhesion molecule and later as a receptor for neuronal guidance cues. NRP1 is now also well recognized for its roles in angiogenesis and maintenance of vessel integrity (13) (14) (15) . Monocytes/ macrophages expressing NRP1 are proangiogenic and facilitate neovascularization in the mature central nervous system (CNS) and in tumors (16, 17) . Given the roles of NRP1 in angiogenesis (14, 15) , lipid uptake (12) , and the propensity of NRP1 + macrophages to promote vascularization (16, 17) , we investigated the implication of NRP1-expressing myeloid cells in obesity.
Here, we show that NRP1-expressing ATMs are critical mediators of protective inflammation during weight gain. Our data reveal that within the myeloid lineage, NRP1 is most abundantly expressed by ATMs where it regulates FA availability for -oxidation. ATMs devoid of NRP1 are less efficient at internalizing lipids and shift their metabolism toward carbohydrate-based glycolysis. As a consequence of their dependence on glycolysis, NRP1-deficient macrophages take on a proinflammatory M1-like phenotype, further contributing to metabolic dysfunction. Ultimately, NRP1-expressing myeloid cells influence glucose tolerance and insulin sensitivity, even before excessive weight gain.
with other steady-state tissue-resident macrophages, monocytes, and neutrophils (Fig. 1A) . These data pointed to a potential role of NRP1 + macrophages in adipose tissue homeostasis.
We therefore placed adult (8-week-old) C57BL/6 mice on high-fat diet (HFD) (59% fat calories) for 10 weeks, investigated ATM populations by fluorescence-activated cell sorting (FACS), and kept agematched controls for the same duration on regular diet [normal chow diet (NCD); 18% fat calories]. All ATMs in this study were collected from visceral white adipose tissue (VAT) located in the peritoneal cavity. In accordance with other studies, an increase in ATMs was detected in adipose tissue of HFD-fed mice when compared with age-matched controls on NCD ( fig. S1A ). This was paralleled by a proportionate increase in NRP1 + ATMs (Fig. 1B) . However, there was no change in numbers of systemic, circulating NRP1 + monocytes, nor was their surface expression of NRP1 [mean fluorescence intensity (MFI)] detected after 4 weeks of HFD when compared with NCD (Fig. 1C) . This suggests that circulating monocytes do not up-regulate NRP1 at the onset of obesity, and there is a selective accretion of NRP1 + ATMs in the adipose tissue of HFD-fed mice. Given that NRP1 is expressed by multiple cell types including immune cells (19) , blood vessels (20) , and neurons (21), we next unbiasedly localized NRP1 in expanding adipose tissue. Immunohistochemistry on VAT in both mice fed HFD for 10 weeks and agematched NCD mice (fig. S1B) confirmed robust NRP1 expression on F4/80 + macrophages (white arrows) at the periphery of perilipinlabeled adipocytes, as well as lectin-stained blood vessels. To confirm myeloid expression of NRP1 in VAT, we generated the LysM-Cre/ ROSAEYFP fl/fl myeloid reporter mouse that endogenously expresses yellow fluorescent protein (YFP) in myeloid lineage cells (22) . After 22 weeks of HFD, NRP1 localized predominantly to crown-like structures (CLSs) (white arrowheads), which correspond to agglomerations of phagocytic macrophages surrounding dying and dead adipocytes (Fig. 1D, left) (23) . High-magnification 4′,6-diamidino-2-phenylindole (DAPI) staining confirmed that the YFP + macrophage signal corresponds to clusters of cells (Fig. 1D, bottom) . Together, these data dem onstrate robust expression of NRP1 in ATMs and suggest accretion of NRP1 + macrophages in adipose tissue during HFD-induced weight gain.
NRP1-expressing myeloid cells regulate diet-induced weight gain and glucose tolerance
To elucidate the role of NRP1 + macrophages in adipose tissue homeostasis and weight gain, we generated a LysM-CRE-Nrp1 fl/fl mouse line with NRP1 ablated in cells of myeloid lineage (17) . Deletion of NRP1 in LysM-Cre-Nrp1 fl/fl ATMs was confirmed by FACS (Fig. 1E ). LysM-Cre-Nrp1 fl/fl and its transgenic control LysM-Cre-Nrp1 +/+ or wild-type (WT) mice were fed either NCD or HFD, and weight gain was monitored. When fed NCD, LysM-Cre-Nrp1 fl/fl mice had similar weight gain profiles to the controls (Fig. 1F) ; EchoMRI scans confirmed no significant differences in lean mass or body fat composition, and dual-energy x-ray absorptiometry (DEXA) scan detected similar bone density (Fig. 1F and fig. S1E ). Although weight gain was similar between LysM-Cre-Nrp1 +/+ and LysM-Cre-Nrp1 fl/fl mice fed NCD, the latter already presented with glucose intolerance and decreased insulin sensitivity (Fig. 1G) .
However, when mice were placed on HFD, LysM-Cre-Nrp1 fl/fl mice gained significantly more weight than LysM-Cre-Nrp1 +/+ mice (Fig. 1H) . EchoMRI scans confirmed that weight gain in LysM-CreNrp1 fl/fl mice stems from fat mass increase and not gains in lean mass, and DEXA scans revealed equal bone density (Fig. 1H and fig. S1F ). The observed glucose intolerance and decreased insulin sensitivity in LysM-Cre-Nrp1 fl/fl mice on NCD were exacerbated by HFD (Fig. 1I ) and persisted even at a time point of 16 weeks when weight gain had plateaued and there was no longer any weight discrepancy between LysM-Cre-Nrp1 +/+ and LysM-Cre-Nrp1 fl/fl mice (Fig. 1H ).
NRP1-expressing myeloid cells influence adipocyte hypertrophy, fatty liver, and CLS formation
The increased fat mass phenotype observed in LysM-Cre-Nrp1 fl/fl mice led us to characterize their adipose tissue by immunohistochemistry. We first labeled adipocyte membranes with perilipin ( Fig. 2A) and noted significant enlargement of adipocytes in LysM-Cre-Nrp1 fl/fl mice and a proportional reduction of adipocyte numbers per area after 10 weeks of HFD. Hypertrophic visceral adipocytes are more lipolytic (24, 25) , leading to increased free FA release into the portal vein (26) , which augments the risk of fatty liver. We therefore isolated livers from control and LysM-Cre-Nrp1 fl/fl mice after 10 weeks of HFD and found that mice with deficiency in myeloid NRP1 had larger, heavier livers ( Fig. 2B ) with larger clusters of lipid droplets (Fig. 2C) . In addition to fatty livers, adipocyte hypertrophy also leads to adipocyte necrosis and recruitment of macrophages to form CLS (23) . We observed a significant rise in CLS in LysM-Cre-Nrp1 fl/fl VAT when compared with controls (Fig. 2D ). These data corroborate that myeloid deficiency in NRP1 results in hypertrophic and degenerating adipose tissue, in addition to nonalcoholic fatty liver.
NRP1-expressing myeloid cells contribute to adipose tissue vascularization
Expanding adipocytes require concomitant vascular network growth to maintain oxygen and trophic support. The adipose phenotype of LysM-Cre-Nrp1 fl/fl mice led us to question whether adipose vasculature was also affected by deficiency in myeloid-resident NRP1. Nonbiased transcriptomic analysis by RNA sequencing (RNA-seq) and gene set enrichment analysis (GSEA) of NRP1-deficient peritoneal macrophages revealed a significant decrease in angiogenesis-related genes in knockout macrophages, suggesting that NRP1 contributes to their angiogenic potential (Fig. 3, A and B) . To elucidate the role of NRP1 + myeloid cells in adipose vascularization, we investigated blood vessel structure in VAT. Isolectin B4 (lectin) labeling revealed compromised vasculature in LysM-Cre-Nrp1 fl/fl mice under either HFD or NCD (Fig. 3, C and D) , with decreased vessel length and vessel area and increased lacunarity indicative of disorganized vascularization (27) . These results are consistent with the proangiogenic role of NRP1 mononuclear phagocytes in the CNS (17) and in tumors (16) . Because compromised blood supply can lead to hypoxia, we probed the adipose tissue of control and mice with NRP1-deficient myeloid cells. Significantly more hypoxic zones were detected in LysM-Cre-Nrp1 fl/fl VAT by pimonidazole adduct staining (Fig. 3E) (28) . These results suggest that myeloid-resident NRP1 drives adipose tissue vascularization and mitigates hypoxia in obesity.
Macrophage-resident NRP1 mitigates cytokine release and proinflammatory polarization A heightened inflammatory state is a key feature of hypoxic and hypertrophic adipose tissue. We therefore sought to gain further insight into the role of myeloid-resident NRP1 on ATM polarization. Cell-sorted ATMs isolated from VAT of HFD-fed ( (I) GTT (n = 9 to 10, two experiments) and ITT (n = 6, two experiments) of control and LysM-Cre-Nrp1 fl/fl mice 16 weeks on HFD (n = 3). White arrows denote NRP1 + ATMs, and white arrowheads denote NRP1 + CLSs. *P < 0.05, **P < 0.01, ***P < 0.001, Student's unpaired t test (B, C, and E) or two-way ANOVA with Bonferroni post hoc test (F to I).
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of proinflammatory genes interleukin-6 (Il-6), tumor necrosis factor- (Tnf-), and interleukin-1 (Il-1) (Fig. 4B ). GSEA revealed a significant enrichment in Molecular Signatures Database (MSigDB) (29) hallmark inflammatory response genes in NRP1-deficient peritoneal macrophages, suggesting that NRP1 mitigates macrophage inflammation (Fig. 4 , C and D). These data are consistent with findings that NRP1 expression is associated with an M2 macrophage polarization because its expression is increased in macrophages cultured in conditions that promote M2 activation (30) . Within the VAT of HFD-fed LysM-Cre-Nrp1 fl/fl mice, we detected a significant increase in ATMs (Fig. 4E ) and a trend-like increase in neutrophils ( Fig. 4F ) (see gating scheme, fig. S5A ). To determine whether macrophage polarization differed in the absence of NRP1, we quantified expression of the M2 marker CD206 on all ATMs (Fig. 4 , G and H) and observed a significant decrease in CD206 + ATMs in LysM-Cre-Nrp1 fl/fl VAT and a significant increase in proinflammatory CD206 − ATMs (Fig. 4G ). In agreement with the proinflammatory M1 phenotype of NRP1-deficient mice, plasma levels of proinflammatory TNF-, IL-1, and IFN- (interferon-) rose in LysM-Cre-Nrp1 fl/fl mice (Fig. 4I) . Together, these data identify a skewed polarization of NRP1-deficient macrophages toward M1 during diet-induced obesity (DIO) that is compounded by heightened accretion of ATMs in LysMCre-Nrp1 fl/fl mice.
Deficiency in myeloid-resident NRP1 affects systemic metabolism
Given the propensity of mice with NRP1-deficient myeloid cells to gain more weight when on HFD, we set out to investigate whether this weight gain was due to increased anabolism or reduction of activity-dependent energy expenditure. We measured food intake and activity (beam breaks) using a telemetry-based monitoring system. We did not observe any difference in total daily food consumption between control and LysM-Cre-Nrp1 fl/fl mice fed NCD (Fig. 5A ). Furthermore, no overall differences in daily activity were detected ( Fig. 5B  and fig. S2A ). LysM-Cre-Nrp1 fl/fl mice consumed slightly less HFD than control LysM-Cre-Nrp1 +/+ mice ( Fig. 2C ), indicating that hyperphagia was not driving weight gain. In addition, total activity did not differ significantly, suggesting that the accelerated weight gain of LysM-Cre-Nrp1 fl/fl mice cannot be attributed to reduced activity either ( Fig. 5D and fig. S2B ). Metabolic chamber analysis was performed at 9 to 10 weeks after initiation of HFD, a time period where LysM-CreNrp1 fl/fl had gained significantly more weight than control LysM-CreNrp1 +/+ mice (ranging from 4 to 15 weeks of HFD feeding) (Fig. 1H ). Because accelerated weight gain in LysM-Cre-Nrp1 fl/fl HFD mice could not be attributed to increased food consumption or decreased activity, we sought to characterize the metabolic phenotype of these mice via indirect calorimetry. After acclimatization, data were collected + -labeled VAT and quantification of CLSs (n = 13) (magnification, ×10; scale bars, 100 m). *P < 0.05, **P < 0.01, ***P < 0.001, Student's unpaired t test.
and averaged over a 7-day period. LysM-Cre-Nrp1 fl/fl mice on NCD had similar VO 2 compared with controls, with a slight increase between the transition from light to dark and vice versa (Fig. 5E and  fig. S2C ). This was mirrored by modestly increased light cycle heat production ( Fig. 5F and fig. S2D ). Furthermore, the respiratory exchange ratio (RER) of LysM-Cre-Nrp1 fl/fl mice was also significantly lower in the dark cycle (Fig. 5G and fig. S2E ), suggesting a systemic baseline preference for lipids over carbohydrates during periods of activity, likely due to greater availability of FAs in these mice (see below). When fed HFD, LysM-Cre-Nrp1 fl/fl mice showed considerably lower VO 2 ( Fig. 5H and fig. S2F ) and heat production ( Fig. 5I  and fig. S2G ), indicative of reduced lipid catabolism in these mice. However, discrepancies in RER observed in NCD were abolished with HFD ( Fig. 5J and fig. S2H ) because lipids became the predominant combustion source for both mouse strains on HFD. Furthermore, although LysM-Cre-Nrp1 fl/fl mice maintained similar food intake and activity levels when on HFD, their catabolic rates were significantly reduced, causing accumulation of lipid-based calories.
In addition, levels of plasma low-density lipoprotein (LDL) cholesterol were increased in LysM-Cre-Nrp1 fl/fl mice after 10 and 22 weeks on HFD ( fig. S2I ). Similar changes were seen in total cholesterol ( fig. S2J ). Cholesterol/high-density lipoprotein (HDL) ratios were significantly higher after 22 weeks on HFD ( fig. S2K ), suggesting that a prolonged HFD exacerbates the metabolic phenotype of LysM-Cre-Nrp1 fl/fl mice. Together, these data further characterize imbalances in lipid metabolism observed in the LysM-Cre-Nrp1 fl/fl mice. 18-week-old mice fed HFD for 10 weeks (magnification, ×30; scale bar, 50 m) (left) with quantification for vessel length, area, and lacunarity (n = 6 to 11 per group). (E) Pimonidazole adduct staining of control or LysM-Cre-Nrp1 fl/fl mice after 10 weeks on HFD (magnification, ×10; scale bar, 100 m) (left) and quantification of hypoxyprobe stain (right) (n = 7 to 8). *P < 0.05, **P < 0.01, ***P < 0.001, Student's unpaired t test.
NRP1 regulates lipid uptake in macrophages
FA uptake is a key function of macrophages in adipose tissue, including during clearance of lipid debris from necrotic adipocytes. Given the accumulation of long-chain FAs in obese adipose tissue (31, 32) , we assessed the capacity of cell-sorted ATMs from control and LysM-Cre-Nrp1 fl/fl mice to uptake FAs using a long-chain FA analog (C1-BODIPY-C12; an 18-carbon FA). NRP1-deficient ATMs took up significantly less FAs than control macrophages (Fig. 6A) , a finding confirmed in peritoneal macrophages (Fig. 6B) . In addition, systemic administration of C1-C12 BODIPY revealed significantly elevated levels of the tagged FAs in VAT and liver of LysM-Cre-Nrp1 fl/fl mice compared with plasma and heart (Fig. 6C) , further substantiating the involvement of NRP1 + macrophages in removing excess lipids in vivo.
To determine whether NRP1 affected lipid uptake in macrophages, we stained for neutral lipids within macrophages with Oil Red O. Oil Red O stain was significantly reduced in LysM-Cre-Nrp1 fl/fl peritoneal macrophages incubated in adipocyte-conditioned medium (Fig. 6D) . Because adipocyte and macrophage media differ in glucose and insulin concentration, we assessed whether the decrease in internalized lipids in NRP1-deficient macrophages also occurred in nonconditioned media, including adipocyte medium with and without insulin, as well as macrophage medium. In all conditions, NRP1-deficient macrophages sequestered significantly fewer neutral lipids than controls ( fig. S3 , A to C). When assessing the transcriptome of NRP1-deficient macrophages by RNA-seq, the MSigDB hallmark FA metabolism gene set (33) revealed that only four genes were differentially regulated when compared with WTs: Auh, Idi1, Cpt2, and Ehhadh (Fig. 6E) . No significant change was detected in expression levels of the lipid and glucose transporters Fatp3 or Glut4 in adipose tissue of HFD-fed LysM-Cre-Nrp1 fl/fl and control mice ( fig. S3, D and E) . Furthermore, within the hallmark adipogenesis gene set, which includes the FA uptake facilitator Cd36, the FA carrier protein Fapb4, and the cholesterol efflux regulatory protein Abca1, only Cpt2 and Gphn were up-regulated (Fig. 5F ). In addition, no significant changes were detected in lipid digestion, mobilization and transport, or mitochondrial FA -oxidation gene sets (Fig. 5, G and H) . Together, these data suggest that knockdown of Nrp1 in myeloid cells does not affect the expression levels of the machinery for FA transport, metabolism, or -oxidation and rather points to a role for NRP1 in lipid uptake.
Deficiency in NRP1 shifts macrophage energy metabolism toward glycolysis
Given the greater adiposity in HFD-fed LysM-Cre-Nrp1 fl/fl mice (Fig. 1H) and that FA uptake was impaired in NRP1-deficient macrophages (both ATM and peritoneal), we questioned whether pathways of energy metabolism were differentially engaged in control and NRP1-deficient peritoneal macrophages. We therefore performed functional metabolic analysis specifically assessing rates of glycolysis and FA -oxidation.
Increased glycolysis was detected in NRP1-deficient macrophages through measurements of the extracellular acidification rate (ECAR) of surrounding media (Fig. 7A) . Reliance on enhanced glycolytic metabolism was verified by significantly up-regulated glycolytic acidification, glycolysis, and glycolytic capacity (Fig. 7B) , typically detected in classically activated (M1) macrophages (34) . The significantly reduced basal oxygen consumption rate (OCR)/ECAR ratio detected 18-week-old mice after 10 weeks on HFD. Data are means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, Student's unpaired t test (A and C) and two-way ANOVA with Bonferroni post hoc test (B and D to J) (n = 24, four mice per group). All graph points represent an average calculated over 7 days of measurements.
in macrophages from LysM-Cre-Nrp1 fl/fl mice (Fig. 7C ) is characteristic of a highly glycolytic metabolism (35) .
To assess FA oxidation (FAO), we performed baseline OCR measurements on macrophages incubated in bovine serum albumin (BSA) or palmitate. This revealed a small yet significant increase in OCR with palmitate-treated control macrophages (Fig. 7, D and E) , but no difference in NRP1-deficient macrophages (Fig. 7E) , indicative of low rates of FAO occurring in control but not LysM-Cre-Nrp1 fl/fl macrophages. A significantly reduced maximal respiratory rate was detected in NRP1-deficient macrophages compared with controls in the presence of both BSA and palmitate (Fig. 7F) ; however, no significant differences between BSA and palmitate treatments were detected by ECAR (Fig. 7G) . Notably, the maximal respiratory rate in the presence of palmitate was significantly lower in LysM-Cre-Nrp1 fl/fl macrophages compared with BSA. Therefore, exogenous lipids further reduce the mitochondrial efficiency of NRP1-deficient macrophages, indicative of impaired long-chain FA utilization, signifying that an environment found in obese adipose tissue would further compromise energy metabolism within these macrophages. Together, these data suggest that NRP1 participates in FA uptake into the macrophage and allows for -oxidation, which is associated with less aggressive macrophage polarization. In the absence of NRP1, macrophages favor glycolysis. , and (H) lipid digestion, mobilization, and transport (M1023). *P < 0.05, **P < 0.01, ***P < 0.001, Student's unpaired t test.
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Transfer of NRP1-expressing hematopoietic cells improves the metabolic phenotype of LysM-Cre-Nrp1 fl/fl mice To establish that the effects of NRP1 loss are dependent on loss of NRP1 in the hematopoietic compartment, we next investigated whether bone marrow transfer would restore metabolic health to LysM-CreNrp1 fl/fl mice. We transferred bone marrow from adult LysM-CreNrp1 fl/fl mice and LysM-Cre-Nrp1 +/+ control mice to lethally irradiated CD45.1 WT animals (Fig. 8A) . Eight weeks after bone marrow transplantation, the circulating population of monocytes expressed donor mouse phenotypes attesting to successful transfer ( fig. S5, A and B) , and no weight differences among groups were detected ( fig. S5, C  and D) . No significant differences were noted in glucose tolerance of LysM-Cre-Nrp1 fl/fl recipient mice transplanted with CD45.1 WT bone marrow compared with LysM-Cre-Nrp1 +/+ recipient mice transplanted with CD45.1 WT bone marrow ( fig. S5E ), indicating that WT bone marrow-derived cells improve glucose tolerance. Furthermore, transplantation with LysM-Cre-Nrp1 fl/fl bone marrow to CD45.1 recipient mice significantly compromised their glucose tolerance when compared with CD45.1 recipient mice transplanted with LysMCre-Nrp1 +/+ bone marrow ( fig. S5F ). Chimeras were then placed on HFD for 10 weeks, and their VAT was probed for reconstitution differences. Donor mice ATMs and B and T lymphocytes comprised most of the VAT populations probed (Fig. 8B and fig. S5, I to K). Difference in glucose tolerance was further exacerbated after HFD for WT mice reconstituted with LysM-Cre-Nrp1 fl/fl bone marrow recipients, whereas the glucose tolerance of CD45.1 WT bone marrow recipients did not differ (Fig. 8C and fig. S5 , G and H). In addition, whereas recipients of control LysM-Cre-Nrp1 +/+ bone marrow did not differ in weight gain upon HFD, recipients of LysM-Cre-Nrp1 fl/fl bone marrow gained significantly more weight (Fig. 8D) . These results demonstrate that the LysM-Cre-Nrp1 fl/fl phenotype is dependent on loss of NRP1 in the hematopoietic compartment. In addition to confirming the importance of NRP1 + myeloid cells in weight gain and glucose tolerance, these results also suggest that circulating monocytes contribute to glucose intolerance and weight gain (Fig. 8E) .
DISCUSSION
The present study identifies a subset of ATMs that accumulate in adipose tissue and promote healthy adipose expansion while safeguarding against metabolic complications ensuing from elevated caloric intake. More precisely, we demonstrate a critical role for NRP1 in driving FA uptake in ATMs and hence substrate availability for consumption in -oxidation that typically fuels a reparative and homeostatic M2 phenotype. Inefficient at burning FAs, NRP1-deficient macrophages revert to a characteristic aggressive glycolysis-reliant M1-like phenotype and contribute to tissue dysfunction, glucose intolerance, and insulin insensitivity. Therefore, in the absence of myeloid-resident NRP1, FAs are not efficiently catabolized by macrophages, contributing to rapid weight gain. Our findings also support the notion that adipose tissue plasticity is critical for healthy weight gain and implicate NRP1 + ATMs in the process. In this regard, lack of NRP1 on ATMs perturbs adipose vasculature, leading to hypoxic zones in VAT and compromised glucose tolerance both during normal development and in DIO. Bone marrow transfer of NRP1 + cells improves glucose homeostasis, suggesting that weight gain and glucose tolerance can be significantly modulated through transferred hematopoietic cells.
Although a local proinflammatory response in adipocytes has been suggested to be an adaptive measure to enable safe storage of excess nutrients (8) , our study provides evidence that hematopoietic expression of NRP1 is sufficient to influence adipose tissue expansion and affect overall metabolic health. Our data also highlight the importance of adequate matching of adipose vascular supply through proportional, concomitant vascularization during development as well as during adult fat pad expansion. Adipose tissue angiogenesis has been proposed to be essential for fat pad expansion and therefore a potential process to target therapeutically for morbid weight gain, much as had been proposed for tumor growth (36) (37) (38) (39) (40) (41) . Yet, adipose neovascularization also provides adequate oxygen and trophic support, FA exchange, and evacuation lines for metabolic waste products. When adipocyte hypertrophy outpaces blood vessel growth, hypoxic zones form, influencing macrophage polarization and exacerbating inflammation (42) (43) (44) (45) . Hence, vascular rarefication or antiangiogenic strategies in expanding adipose tissue may contribute to metabolic complications associated with obesity. Therefore, our data support the importance of adipose vascular plasticity during adult fat pad expansion.
Here, we specifically interrogated on the role of myeloid-resident NRP1, yet NRP1 is also expressed by murine brown adipocytes (46) and bone marrow adipocytes (47) , where it inhibits hematopoiesis (48) . Hence, it will be interesting to assess the local contribution of NRP1 in these tissues to overall adipose dynamics. Notably, although our findings on ATM-resident NRP1 were corroborated in vitro, the LysM (or Lys2) promoter used in our study to express Cre in macrophages in vivo is also expressed in neutrophils and, to an extent, in a subset of T and B cells (49) . Neutrophils express high levels of LysM, and therefore, we cannot fully discount their contribution to the phenotype observed. However, ATMs express significantly more Nrp1 than neutrophils, and the macrophage population remains most affected by the targeted deletion. Future work elucidating the mechanisms by which NRP1 promotes FA uptake and -oxidation will be required. Insight gained may be important toward designing therapeutic modalities for metabolic syndromes.
Overall, our work identifies NRP1 + ATMs as promoters of healthy weight gain and describes a myeloid-based mechanism for glucose intolerance even independent of excessive weight gain because type 2 diabetes mellitus can occur in individuals with a normal body mass index (50) . Our study further provides in vivo support for the notion that macrophage polarization is intrinsically associated with energy metabolism and that homeostatic macrophages rely heavily upon FAs delivered via NRP1, a slower yet sustained means of energy production. More broadly, our study provides insight into the essential role of macrophages in adipose tissue homeostasis. fl/fl recipient mice were lethally irradiated (12 Gy) and reconstituted with 5 × 10 6 bone marrow cells. Glucose tolerance tests (GTTs) were performed on chimeric mice 8 weeks after reconstitution and then put on HFD for 10 weeks.
MATERIALS AND METHODS
Mice
Metabolic chamber analysis
Mice were acclimatized to metabolic cages for 7 days, and data were collected over 7 subsequent days. LabMaster/PhenoMaster system from TSE Systems (Germany) measured indirect calorimetry, O 2 consumption and CO 2 production, RER, energy expenditure, food and water intake, and locomotor activity by infrared beam breaking. Mice were placed in metabolic chambers for a 1-week acclimatization period, followed by 1 week of data collection.
ImmGen skyline data set
ImmGen data phase 1 [Gene Expression Omnibus (GEO) accession code GSE15907] and phase 2 (GSE37448) were extracted and normalized in R by Robust Multi-array Average (RMA), and antilog values were plotted.
Glucose tolerance test
Mice were starved for 12 hours overnight. Blood glucose was measured (Accu-Chek, Roche) at baseline and at 15, 30, 60, 120, and 240 min after intraperitoneal injection of 10% d-glucose (2 mg/kg; Sigma).
Insulin tolerance test
Mice were starved for 5.5 hours (in the morning). Blood glucose was measured at baseline and at 30, 60, and 120 min after intraperitoneal injection of insulin (0.75 U/kg; Novo Nordisk).
FACS of ATMs
White adipose tissue was collected, weighted, and homogenized in Dulbecco's modified Eagle's medium (DMEM)/F12 medium and then incubated with collagenase D (1 mg/ml; Sigma) at 37°C for 45 min. EDTA was then added at a concentration of 10 mM, and the mix was incubated for an extra 5 min. Homogenates were then filtered with a 70-m cell strainer and centrifuged. Pellets were resuspended and incubated in lysis buffer (10 mM KCHO 3 , 150 mM NH 4 Cl, 0.1 mM EDTA) for 5 min at room temperature and centrifuged. Pellets were resuspended in 1× phosphate-buffered saline (PBS) and filtered with a 100-m cell strainer. Cell suspensions were incubated with the Zombie Aqua Fixable Viability Kit (BioLegend) for 15 min at room temperature. Cells were then incubated with LEAF purified anti-mouse CD16/32 (BioLegend) for 15 min at room temperature to block Fc receptors. Cells were then incubated for 25 min at 4°C, with anti bodies listed in table S1. For analysis of CD206 expression, permeabilization and fixation of the cells were done using the Cytofix/Cytoperm Kit (BD Biosciences) at 4°C for 20 min. Cells were then incubated with rat serum (Cedarlane) for 25 min at 4°C to block intracellular receptors. Cells were then stained with Brilliant Violet 421 anti-mouse CD206 (MMR) (BioLegend) for 25 min at 4°C. FACS was performed on a Fortessa (BD Biosciences) device, and data were analyzed using FlowJo software (version 7.6.5).
ATM FA uptake
The fluorometric Free Fatty Acid Uptake Assay Kit (Abcam) was used to detect ATM FA uptake. Cell-sorted ATMs were isolated from VAT of HFD-fed LysM-Cre-Nrp1 +/+ or LysM-Cre-Nrp1 fl/fl mice and plated at a density of 100,000 cells per well in a 96-well plate. After overnight incubation in complete DMEM/F12 medium, ATMs were serum-deprived for 1 hour in 100-l basal medium. FA dye loading solution (100 l) was added to each well (including blanks) and incubated for 30 min. Fluorescence intensity was measured at an excitation wavelength of 485 and at an emission wavelength of 515 nm.
Glycolysis and FAO assays
Real-time analysis ECAR and OCR were performed on LysM-CreNrp1 +/+ and LysM-Cre-Nrp1 fl/fl peritoneal macrophages with the XF-24 Extracellular Flux Analyzer (Seahorse Bioscience). For glycolysis assays, macrophages were cultured in a 24-well Seahorse plate at a seeding density of 1.75 × 10 5 cells per well. Before experiment, medium was changed to Seahorse DMEM containing 2 mM glutamine and 0.5% BSA. Glucose (10 mM; Sigma), oligomycin (1.5 M; Sigma), and 2-deoxy-dglucose (2-DG) (50 mM; Sigma) were sequentially added. For FAO assays, macrophages were cultured in a 24-well Seahorse plate at a seeding density of 2 × 10 5 cells per well. Before experiment, medium was changed to Seahorse DMEM containing 10 mM glucose, 2 mM glutamine, 1 mM pyruvate, 1 mM carnitine, and 0.5% BSA (BSA group). Selected wells received an additional 0.3 mM palmitate (palmitate-BSA group; Sigma). Oligomycin (1.5 M; Sigma), carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP) (5 M), 1 M rotenone, and 2 M antimycin A were sequentially added. Upon completion of glycolysis and FAO experiments, cells were lysed and their protein content was quantified. OCR and ECAR data were normalized to protein content.
Quantitative real time polymerase chain reaction analysis RNA extraction was performed with 100 to 500 mg of frozen (−80°C) VAT after the TRIzol Reagent Protocol (Invitrogen). Total RNA (1 g) was reverse-transcribed according to the manufacturer's instructions (iScript cDNA Synthesis Kit, Bio-Rad). Quantitative polymerase chain reaction (qPCR) was performed using SYBR Green (Bio-Rad) and 40 ng of complementary DNA (cDNA) per reaction (7500 Real-Time PCR System, Applied Biosystems). Expression levels were normalized to the expression of -actin. Primer (Integrated DNA Technologies) sequences are listed in table S2.
Vascular analysis
AngioTool analysis (27) was performed on 10× epifluorescent photomicrographs of lectin-stained VAT.
Immunohistochemistry
VAT tissue was fixed in 4% paraformaldehyde (PFA) (Electron Microscopy Sciences) for 48 hours and then incubated in 20% methanol (Chaptec) for 10 min and rinsed in PBS. One-hour blocking in 3% BSA (HyClone, GE) plus 0.3% Triton X-100 (Sigma) preceded overnight incubation with rhodamine-labeled Griffonia (Bandeiraea) Simplicifolia Lectin I (Vector Laboratories Inc.), anti-rat F4/80 [donkey immunoglobulin G (IgG), eBioscience], anti-rabbit perilipin (donkey IgG, Abcam), and anti-rat NRP1 antibody (donkey IgG, R&D Systems) at 4°C. Alexa Fluor secondary antibodies were incubated for 2 hours at 20°C. The VAT was then mounted onto a microscope slide, and images were taken by confocal microscope.
In vivo hypoxyprobe detection
Hypoxyprobe injections were performed on LysM-Cre-Nrp1 +/+ and LysM-Cre-Nrp1 fl/fl male mice fed with HFD for 10 weeks or agematched NCD. Pimonidazole (60 mg/kg; Hypoxyprobe-Red549, Hypoxyprobe) diluted in 0.9% saline (Hospira) was injected intraperitoneally. Mice were euthanized 1 hour after hypoxyprobe injection. VAT samples were collected and fixed in 4% PFA (Electron Microscopy Sciences) for pimonidazole adduct immunohistochemistry.
RNA-seq sample preparation and sequencing
Total RNA was isolated from macrophages using the RNeasy Mini Kit (Qiagen). The mRNA was then purified from 1 g of total RNA using the Dynabeads mRNA DIRECT Micro Kit (Thermo Fisher Scientific). Whole-transcriptome libraries were prepared using the Ion Total RNA-seq Kit v2. The yield and size distribution of the amplified libraries were assessed with the Agilent Bioanalyzer using the DNA 1000 Kit. Sequencing was performed on an Ion Chef instrument (Ion Torrent, Thermo Fisher Scientific).
cDNA library construction and sequencing Analysis was performed using the Torrent Suite software v4.4 (Thermo Fisher Scientific) and the whole Transcriptome Analysis Plugin version 4.2-r7 (Thermo Fisher Scientific). The whole Transcriptome Analysis Plugin aligns reads on mouse reference genome (mm10) using TopHat2, and then unmapped reads are aligned using Bowtie2 and merged together. FPKM (fragment per kilobase of transcript per million) is calculated using Cufflinks.
Gene set enrichment analysis GSEA was conducted using GSEA v2.2.1 software provided by Broad Institute of Massachusetts Institute of Technology and Harvard University. We used GSEA to validate correlation between molecular signatures in phenotypes of interest. Enrichment analysis was conducted with log 2 -normalized FPKM data generated by the TopHat/Cuffdiff command pipeline: FPKM values were converted as ratios (FPKM x / [FPKM Control ] mean) and then log 2 -normalized (log 2 [ratio]) and median-centered (log 2 ratio − [log 2 ratio Control ] mean). Default parameters were changed as follows: Gene sets of interest were found in a catalog of functional annotated gene sets from MSigDB; phenotype was permutated 1000 times; phenotype label was defined as "Nrp1 knockout" versus "Control"; gene sets smaller than 15 and larger than 500 were excluded from the analysis; statistic used to score hits was defined as "weighted p2," and the class separation metric used was "t test."
Statistical analyses
We used an unpaired two-tailed Student's t test and one-way or twoway analysis of variance (ANOVA) with Bonferroni post hoc analysis, where appropriate, to compare the different groups. P < 0.05 was considered statistically different, denoted graphically as *P < 0.05, **P < 0.01, and ***P < 0.001. Data are means ± SEM. Biological experiment numbers were listed in figure legends. 
Primary macrophage culture
Bio-Plex analysis
See Supplementary Experimental Procedures.
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